Medipost Co Ltd

078160

Company Profile

  • Business description

    Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

  • Contact

    21, Daewangpangyo-ro 644
    Bundang-gu
    Gyeonggi-do
    Seongnam
    KOR

    T: +82 234656650

    http://www.medi-post.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    324

Stocks News & Analysis

stocks

Is this still an ASX share to own forever?

Find out how this defensive player has fared after earnings.
stocks

After earnings, is Nvidia stock a buy, a sell, or fairly valued?

No signs of a slowdown in demand for Nvidia’s chips, and the long-term picture looks bright.
stocks

Short-term pain for long-term gain for undervalued ASX share

Cost reductions lower our profit estimates but should lead to improved long-term outcomes.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,010.10117.10-1.28%
CAC 407,719.7165.460.86%
DAX 4023,594.80107.470.46%
Dow JONES (US)45,271.2324.58-0.05%
FTSE 1009,177.9961.300.67%
HKSE25,343.43153.12-0.60%
NASDAQ21,497.73218.101.02%
Nikkei 22541,938.89371.60-0.88%
NZX 50 Index13,045.6729.14-0.22%
S&P 5006,448.2632.720.51%
S&P/ASX 2008,738.80120.20-1.36%
SSE Composite Index3,813.5644.58-1.16%

Market Movers